Entries by connective

We have reached 100,000 products

We are proud that we can now give more choice to customers than ever before as we reach our important milestone of 100,000 products on our catalog. Our expanding product range now includes a range of non-primary antibody products including biochemicals, secondaries, proteins, peptides, lysates, assays and other kits. Our commitment to customers still remains […]

HRH The Duke of York visits Abcam to see the Cambridge Phenomenon in action

October 09, 2012:  Abcam gave a special welcome to His Royal Highness The Duke of York at their global headquarters in Cambridge. The Duke’s tour of Abcam was part of a larger visit showcasing Cambridge as a high-tech cluster where the combination of the University, flexible funding sources and existing know-how can foster the growth […]

Rabbit monoclonal antibodies, available from Abcam following acquisition of Epitomics

September 4, 2012: Abcam is pleased to announce that following the completion of the acquisition of Epitomics, customers in Europe are now able to purchase Epitomics’ line of high quality RabMAbs® (Rabbit Monoclonal Antibodies) directly from our website. RabMAbs® provide the combined benefits of superior antigen recognition of the rabbit immune system with the specificity […]

New range of Biochemicals now available from Abcam

January 9, 2012: Abcam has today launched a new range of exceptional quality and high performance biochemicals.  The products include high purity agonists, antagonists, channel blockers, enzyme inhibitors and signaling tools for life science researchers. The acquisition extends Abcam’s product portfolio into bioactive small molecules and is in line with the Company’s vision of becoming […]

Abcam acquires Ascent Scientific, a specialist provider of biochemicals

September 13, 2011: Abcam plc, is pleased to announce it has entered into an agreement to acquire Ascent Scientific Ltd, a specialist provider of biochemical reagents. The acquisition extends Abcam’s product portfolio into small molecules and is in line with the Company’s vision of becoming the world’s leading supplier of protein research tools. Ascent Scientific […]

Abcam acquires MitoSciences in deal which enhances immunoassay portfolio

24 May 2011: Abcam is pleased to announce it has entered into an agreement to acquire MitoSciences Inc. a leading provider of cutting edge mitochondrial research tools.  This represents a further step towards Abcam’s mission of becoming the leading supplier of protein research and detection tools. MitoSciences has over 200 products in the areas of […]

Jonathan Milner wins Entrepreneur of the Year award

Abcam’s CEO wins the prestigious AIM award for Entrepreneur of the Year, 2010 Jonathan says; “It’s an honour to be voted Entrepreneur of the Year and I accept the award on behalf of everyone at Abcam. The success of Abcam is a result of all employees striving for excellence in every aspect of our business, […]

Abcam’s Jonathan Milner wins CEO of the Year

European Mediscience Awards congratulate Jonathan Milner in winning the Chief Executive Officer of the year award at the Mediscience Awards 2010 Jonathan Milner said “It’s a great privilege to win this award. It reflects the hard work and commitment of everyone at the company, all of whom I would like to thank.” On behalf of […]